8-K

Company

Enliven Therapeutics, Inc.

Filed

April 11, 2024

Period of Report

April 11, 2024

Accession Number

0001193125-24-092522

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →